Bio Detection dogs identify COVID-19 with up to 94% accuracy lshtm.ac.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lshtm.ac.uk Daily Mail and Mail on Sunday newspapers.
Novacyt share price falls after failure to renew UK supply contract
Fri, 9th Apr 2021 15:01
(Alliance News) - Novacyt SA shares fell 31% on Friday after the biotechnology firm announced its supply contract with the UK Department of Health & Social Care was not being renewed.
In a trading update on Friday Novacyt said: Both parties are now in dispute regarding the contract, which may have a material impact on the fourth quarter of 2020 revenue. However, the company has taken legal advice and believes it has strong grounds to assert its contractual rights.
Novacyt delivered revenue for the first quarter of 2021 of GBP72.6 million, with 50% of this attributable to sales to the DHSC.
Progress towards inclusive blood donation thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site, we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, as-is , and you use it at your own risk. The contents of all Chat messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates. London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.
(2)
Press Release
Hørsholm, Denmark (26 January 2021) - Allarity Therapeutics A/S ( Allarity or the Company ) today announced plans to further test the antiviral activity of stenoparib, its PARP inhibitor, against SARS-CoV-2 lineage B.1.1.7, also known as Coronavirus Variant B117 (the British variant ), at the Pathogen and Microbiome Institute at Northern Arizona University (NAU).
The virus variant was labelled Variant of Concern 202012/01 by Public Health England (PHE), an agency of the UK Department of Health & Social Care, in a publication on 21 December 2020, after it was found to have spread rapidly within the UK, and the PHE assessed that this variant has a substantially increased transmissibility compared with other Coronavirus variants. This variant has also been identified in the U.S. in several states.